317 related articles for article (PubMed ID: 19962890)
1. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
Ramalingam P; Ganapaty S; Rao ChB
Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of 3-hydrazono-1H-2-indolinones with antituberculosis activity.
Karah N; Terzioĝlu N; Gürsoy A
Arzneimittelforschung; 1998 Jul; 48(7):758-63. PubMed ID: 9706377
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
Puratchikody A; Natarajan R; Jayapal M; Doble M
Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents.
Tandon VK; Yadav DB; Maurya HK; Chaturvedi AK; Shukla PK
Bioorg Med Chem; 2006 Sep; 14(17):6120-6. PubMed ID: 16806945
[TBL] [Abstract][Full Text] [Related]
10. Conventional and microwave assisted synthesis of 2-oxo-4-substituted aryl-azetidine derivatives of benzotriazole: a new class of biological compounds.
Dubey A; Srivastava SK; Srivastava SD
Bioorg Med Chem Lett; 2011 Jan; 21(1):569-73. PubMed ID: 21130647
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and mannich bases as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendra Prasad Y; Mallikarjuna BP; Chandrashekar SM
Eur J Med Chem; 2010 Nov; 45(11):5120-9. PubMed ID: 20797808
[TBL] [Abstract][Full Text] [Related]
12. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide.
Ortega MA; Sainz Y; Montoya ME; Jaso A; Zarranz B; Aldana I; Monge A
Arzneimittelforschung; 2002; 52(2):113-9. PubMed ID: 11878199
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Shingalapur RV; Hosamani KM; Keri RS
Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A
Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimycobacterial evaluation of novel 5,6-dimethoxy-1-oxo-2,5-dihydro-1H-2-indenyl-5,4-substituted phenyl methanone analogues.
Ali MA; Samy JG; Manogaran E; Sellappan V; Hasan MZ; Ahsan MJ; Pandian S; ShaharYar M
Bioorg Med Chem Lett; 2009 Dec; 19(24):7000-2. PubMed ID: 19879757
[TBL] [Abstract][Full Text] [Related]
18. Quinoxaline derivatives as potential antituberculotic agents.
Kunes J; Spulák M; Waisser K; Slosárek M; Janota J
Pharmazie; 2000 Nov; 55(11):858-9. PubMed ID: 11126007
[No Abstract] [Full Text] [Related]
19. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.
Güzel O; Karali N; Salman A
Bioorg Med Chem; 2008 Oct; 16(19):8976-87. PubMed ID: 18804379
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K
Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
